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Abstract: 
Background: With the increasing burden of chronic and age-related diseases, and the rapidly 
increasing number of patients receiving ambulatory or outpatient-based care, nurse-led services 
have been suggested as one solution to manage increasing demand on the health system as they 
aim to reduce waiting times, resources, and costs while maintaining patient safety and 
enhancing satisfaction. 
Objectives: The aims of this review were to assess the clinical effectiveness, economic 
outcomes and key implementation characteristics of nurse-led services in the ambulatory care 
setting.  
Design: A systematic review was conducted using the standard Cochrane Collaboration 
methodology and was prepared in accordance with the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines. 
Data sources: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) 
on The Cochrane Library, MEDLINE EBSCO, CINAHL EBSCO, and PsycINFO Ovid (from 
inception to April 2016).  
Review Methods: Data were extracted and appraisal undertaken. We included randomised 
controlled trials; quasi-randomised controlled trials; controlled and non-controlled before-and-
after studies that compared the effects of nurse-led services in the ambulatory or community 
care setting with an alternative model of care or standard care. 
Results: Twenty-five studies of 180,308 participants were included in this review. Of the 16 
studies that measured and reported on health-related quality of life outcomes, the majority of 
studies (n=13) reported equivocal outcomes; with three studies demonstrating superior 
outcomes and one demonstrating inferior outcomes in comparison with physician-led and 
standard care. Nurse-led care demonstrated either equivalent or better outcomes for a number 
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of outcomes including symptom burden, self-management and behavioural outcomes, disease-
specific indicators, satisfaction and perception of quality of life, and health service use. 
Benefits of nurse-led services remain inconclusive in terms of economic outcomes. 
Conclusions: Nurse-led care is a safe and feasible model of care for consideration across a 
number of ambulatory care settings. With appropriate training and support provided, nurse-led 
care is able to produce at least equivocal outcomes or at times better outcomes in terms of 
health-related quality of life compared to physician-led care or standard care for managing 
chronic conditions. There is a lack of high quality economic evaluations for nurse-led services, 
which is essential for guiding the decision making of health policy makers. Key factors such 
as education and qualification of the nurse; self-management support; resources available for 
the nurse; prescribing capabilities; and evaluation using appropriate outcome should be 
carefully considered for future planning of nurse-led services. 
 
Highlights 
 
What is already known about the topic? 
 Previous systematic reviews showed the effects of nurse-led care were comparable to 
physician-led care in several settings.  
 However, majority of these systematic reviews focussed on single specialty settings, 
were conducted over 10 years ago, and did not provide a detailed synthesis of 
economic and process outcomes.   
 
What this paper adds? 
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 This paper provides an updated systematic review of the literature, confirming that 
nurse-led care produce equivalent or better outcomes compared to physician-
led/standard care in managing chronic conditions in the ambulatory care setting.  
 This paper also suggests a number of important process outcomes such as education 
and qualification of the nurse; self-management support; resources available for the 
nurse; and prescribing capabilities. These factors should be carefully considered for 
future planning of nurse-led services. 
 This paper highlights a lack of high quality economic evaluations and provides 
direction for future economic evaluations of nurse-led services.  
 
Keywords: 
Nurse-led care; nurse-led services; health-related quality of life; chronic conditions; 
economic outcomes; process outcomes; ambulatory care setting; systematic review. 
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1. Background 
With the increasing burden of chronic and age-related diseases, and the rapidly increasing 
number of patients receiving ambulatory or outpatient-based care, nurse-led clinics or services 
have been suggested as one solution to manage increasing demand on the health system as they 
may reduce waiting times, resources, and costs while maintaining patient safety and enhancing 
satisfaction (1, 2). Nurse-led services developed as an advanced practice role for primary 
chronic disease management during the 1990s (3). They are now common in a wide variety of 
clinical and specialist areas and are well established in the USA, UK and Canada in diseases 
such as: rheumatoid arthritis; diabetes; hypertension; cardiac conditions; musculoskeletal 
disorders; cancer; and dermatology.  
Nurses make up the largest workforce in healthcare and can play a fundamental role in 
redesigning healthcare models (4). Nurse-led services are complex interventions involving 
multiple care components (5). They usually follow structured protocols, guidelines and 
algorithms for decision making and are thus associated with adherence to best practice. They 
aim to facilitate increased follow-up for patients and improve concordance with guidelines. 
They are considered to provide safe care, which may result in improved outcomes and 
potentially lower healthcare costs (6). Commonly, in a nurse-led service, nurses assume their 
own patient case-loads, work autonomously and manage a patient’s health through assessment, 
monitoring, nursing interventions, and provision of education and support to patients to 
empower them to manage their own health needs (7). To provide a nurse-led service, nurses 
generally require educational preparation and training specific to each context of practice. The 
International Council of Nurses recommends that a Master’s degree is required for entry level 
(8). The nurse-led care model relies on the adept nurse to have the attributes, skills, and 
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knowledge to competently and comprehensively deliver care (2). Identifying and training such 
nurses requires careful and considered workforce planning. Policy directives, funding and 
education opportunities are required to ensure nurses can assume this role and are able to 
deliver effective and equitable healthcare services (9). One of the most important 
considerations for a nurse-led service is requirements of appropriate qualifications and ongoing 
professional development; this underpins a competent service. Careful planning, 
implementation, accountability and evaluation is required to ensure the service is effective (10). 
 
Several reviews examined nurse-led services for certain health conditions, and suggested these 
services may be beneficial (11-15). In some settings, studies evaluating substitution of 
physicians by nurses have found no differences in health outcomes, with some evidence of 
improved satisfaction (11-15). However, the majority of these reviews are either over 10 years 
old, focussed on single condition/practice settings or did not include economic and process 
outcomes as part of the reviews. The focus of this current review was to examine evidence for 
nurse-led services across all chronic conditions in the ambulatory care setting, where the nurse 
assumed primary responsibility for patient management and care. Furthermore, this review also 
synthesised key information regarding implementation of services and examined the economic 
outcomes of such services. 
 
2. Aims 
The primary aim of this review was to assess the clinical effectiveness of nurse-led services in 
the ambulatory or community care setting. The secondary aims of this review were to examine 
the economic outcomes and to characterize the nurse-led services by describing (i) the training 
and qualification requirements of the nurses; (ii) whether self-management support was a 
component of the nurse-led intervention; (iii) whether the interventions were delivered by nurse 
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practitioners. These three characteristics were perceived to be critical for informing 
development of future nurse-led services during the design of this systematic review.  
 
3. Methods 
This systematic review was prepared in accordance with the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines and was prospectively 
registered in PROSPERO (ID 42016036924). 
 
3.1. Identification of studies and inclusion criteria 
We searched the following electronic databases: Cochrane Central Register of Controlled 
Trials (CENTRAL) on The Cochrane Library (Issue 4, 2016), MEDLINE EBSCO (1966 to 
April 2016), CINAHL EBSCO (1982 to April 2016), and PsycINFO Ovid (1967 to April 2016). 
The searches were restricted to humans and to studies in English. Search terms included 
combinations of terms to describe the intervention (e.g. nurse-led, nurse practitioners, nurse, 
nursing) and the setting (e.g. primary care, community, outpatient, ambulatory, clinics) (See 
Supplementary Material 1). The reference list was also hand searched to further identify 
relevant studies for inclusion.  
 
Only comparative quantitative evaluative studies were included. Study designs included in this 
review are: randomised controlled trials; quasi-randomised controlled trials; controlled and 
non-controlled before-and-after studies. The population of interest were people who received 
nurse-led services in an ambulatory or community care setting. There was no limitation on 
diagnosis. Studies that evaluated nurse-led services provided as part of an inpatient service or 
midwife-led services were excluded. The reviewed interventions were nurse-led services as a 
model of care where the registered nurse has primary responsibility for patient management 
AC
CE
PT
ED
 M
AN
US
CR
IPT
8 
 
and care for a cohort of patients located in an ambulatory or community care setting. Studies 
that used usual care or any other alternative model of care (e.g. physician-led services) as the 
comparator were included. The primary outcome was health-related quality of life (HRQoL). 
For the purpose of this review, the authors believed that this was an appropriate primary 
outcome as it provides a composite measure of issues that are important to a variety of patient 
populations. The HRQoL measures could be generic or disease-specific as measured by the 
trial authors. Secondary outcomes included any health-related outcomes including: symptom 
burden, patient self-management or behavioural outcomes (measured by behavioural uptake), 
condition-related clinical indicators, patient satisfaction, and health service use such as rates of 
hospitalisation, emergency presentation, referrals to health services and medication 
management. In addition, this review also examined economic outcomes and key components 
and attributes of the nurse-led services. 
 
3.2. Study screening 
Two review authors pre-screened all search results (titles and abstracts) for possible inclusion, 
and those selected by either or both authors were subject to full-text assessment. Two review 
authors independently assessed the selected articles for inclusion. Discrepancies were resolved 
by discussion to reach consensus. If a consensus could not be reached, a third review author 
would have been asked to act as an arbiter. However, this was not required. 
 
3.3. Data extraction 
All articles that met the inclusion criteria were included in the review. Data extraction was 
conducted by two authors. Data extracted included: study methods; authors, publication year, 
country, study design, characteristics of participants (including age, disease), content and 
intensity of the interventions, sample size, response rate, outcome measures, intervention 
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resources, study results and the level of evidence of the study. Any discrepancies, errors or 
inconsistencies were resolved by consensus between the two authors through a discussion after 
reviewing the original article. If a consensus could not be reached, a third review author would 
have been asked to act as an arbiter. However, this was not required. All studies were classified 
into non-inferiority or superiority trials as per intended by the trial authors. 
 
3.4. Study quality assessment 
Studies were assessed and reported in accordance with the guidelines in the Cochrane 
Handbook for Systematic Reviews of Interventions (16), which recommends the explicit 
reporting of individual domains including sequence generation for randomisation, allocation 
concealment, blinding of participants, personnel and outcome assessors (assessed for each main 
outcome or class of outcome), incomplete outcome data (assessed for each main outcome or 
class of outcome), selective outcome reporting, and other sources of bias. This led to an overall 
assessment of the risk of bias of the included studies (17). We assessed each risk of bias item 
as either low, unclear or a high risk of bias based on the trial reports and/or additional 
information provided by trial authors. 
 
Two review authors independently assessed the risk of bias in included studies, with any 
disagreements resolved by discussion to reach consensus. We contacted trial authors for 
additional information about the study methods as necessary. If a consensus could not be 
reached, a third review author would have been asked to act as an arbiter. However, this was 
not required.  We incorporated the results of the risk of bias assessment into the review through 
narrative description and commentary about each item. 
 
3.5. Data synthesis and analysis 
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Due to the broad inclusion of this review, the included studies contain a large range of study 
designs (e.g. pre-post, RCT), disease types (e.g. mental illness, cardiovascular), intervention, 
outcome measures (e.g. clinical outcomes, cost-effectiveness). Therefore, a meta-analysis was 
considered inappropriate and a narrative synthesis was planned and undertaken.  
 
4. Results 
4.1. Search results 
A total of 2,863 titles were identified from the initial search. After removing duplicates and 
screening titles and abstracts, 60 full text articles were retrieved and assessed for eligibility. Of 
these 60 articles, 25 studies met the inclusion criteria and were included in this review (Figure 
1, PRISMA flow diagram). 
 
4.2. Characteristics of the included studies 
The 25 included studies involved 180,308 participants and examined nurse-led services in a 
wide range of conditions and care settings caring for adult patients with heart failure and 
cardiovascular disease (17-19); asthma (20, 21); aged care (22); dyspepsia (23); post-intensive 
care(24); pain (25); rheumatology(26, 27); cancer (28, 29); chronic and end-stage kidney 
disease (30, 31); mental health (32); attention deficit hyperactivity disorder (ADHD) (33), and  
diabetes/gestational diabetes (34, 35). One study included patients with both human 
immunodeficiency virus (HIV) and severe mental illness (36). Four studies included patients 
with mixed chronic conditions in the contexts of community health and geriatrics (37-40). 
 
The majority of included studies were conducted in Europe (n=15) (18, 20, 21, 23-28, 32-34, 
37, 38, 40), with the remaining conducted in Australia (n=4) (22, 29, 31, 35), the United States 
(n=3) (19, 36, 39) and Asia (n=3) (17, 30). Most were RCTs (n=19) (18-21, 23-30, 32, 34, 36, 
AC
CE
PT
ED
 M
AN
US
CR
IPT
11 
 
38-40), with five pre-post studies (17, 22, 31, 35, 37) and one non-randomised controlled trial 
(33). Of the 19 RCTs, ten were superiority trials (18, 19, 21, 25, 29, 30, 32, 36, 39) and nine 
were equivalence trials (20, 23, 24, 26-28, 34, 38, 40). The studies had various sizes of samples: 
>1,000 (n=3) (37, 38, 40), between 201 and 1,000 (n=10) (17, 19, 22, 24, 29, 32, 34-36, 39), 
between 101 and 200 (n=7) (18, 20, 21, 23, 25, 27, 28), and ≤100 (n=5) (26, 30, 31, 33). 
Characteristics and key findings are illustrated in Table 1.  
 
4.3. Risks of bias of the included studies 
The risk of bias assessment for each study is outlined in Table 2. The majority of studies 
achieved low risk across most domains of assessment (random sequence generation: n=19; 
allocation concealment: n=11; incomplete outcome data reporting: n=17; selective outcome 
reporting: n=11; and other sources of bias: n=17). For the six non-RCTs, assessment of risks 
related to random sequence generation and allocation concealment were not applicable. Due to 
the nature of nurse-led services, the interventions were not amenable to blinding of participants. 
Accordingly, all 25 studies were rated as high-risk for this domain of assessment. Blinding of 
outcome assessment could have been achieved by using data collectors who were blinded to 
the intervention or objective outcomes such as laboratory markers. However, a total of 11 
studies received a high-risk rating for this domain. 
 
4.4. Outcome measures 
All outcome measures used by the 25 studies could be categorised into HRQoL (general and 
disease-specific), symptom burden, self-management and behavioural outcomes, health 
service/resources use and costs, satisfaction and perception of care, and other clinical indicators 
(See Table 1). Seventeen studies (68%) measured HRQoL using generic (e.g.  SF36, SF12, and 
EQ5D) or disease-specific HRQoL measures. Symptom burden was assessed in 12 studies 
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(48%). Self-management or behavioural outcomes were assessed in five studies (20%). Ten 
studies measured a range of other clinical indicators related to the specialty (40%). Satisfaction 
and perception of the quality of care outcomes were measured in 11 studies (44%). Health 
service/resources use and/or costs were assessed in 16 studies (64%) (see Figure 2). 
 
4.5. Primary outcome 
4.5.1. Health related quality of life 
Of the 25 included studies, 17 measured HRQoL as an outcome measure for evaluation of the 
nurse-led intervention (18-26, 28-30, 32-34, 38, 39). One RCT did not report HRQoL results 
(19). Two studies reported nurse-led interventions improved measures of HRQoL compared to 
standard care or physician-led interventions (18, 23). One RCT(23) investigated the effects of 
a nurse-led clinic follow up for dyspeptic patients after direct access gastroscopy and reported 
improved HRQoL in comparison with GP-led follow up (Mean Difference: MD 140.7, 
p<0.001). A cluster RCT (n=153) evaluating a nurse-led intervention in addition to standard 
care designed to improve self-management in patients with heart failure in a primary care 
setting reported improvements in role function due to physical limitations in comparison with 
a control group (18).  
 
Most studies (n=13) reported equivocal outcomes in HRQoL between a range of nurse-led care 
models and standard care (20-22, 24, 25, 27-30, 32, 33, 38, 39). Of these, eight studies (20, 24, 
26-28, 32, 33, 38) evaluated nurse-led care compared to physician care in rheumatology (26, 
27), respiratory(20), post-cancer surgery follow up (28), mental health(32), ADHD (33), 
general practice (38) and post-intensive care discharge (24) settings; and five (21, 22, 29, 30, 
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39) evaluated the nurse-led care in addition to standard care in the asthma (21), renal (30), 
chronic disease management(39), post-cancer surgery (29), and dementia care (22) settings.  
 
One RCT (n=206) reported patients with type 2 diabetes mellitus receiving care from the nurse-
led intervention showed a small but statistically significant reduction in overall physical 
component scores on the SF36, whereas this did not occur for the group of patients receiving 
GP led care over the 14 month study period (34).  
 
4.6. Secondary outcomes 
4.6.1 Symptom burden 
Twelve RCTs showed that there were either no differences (18, 21, 32, 33, 40-42) or significant 
improvements (23, 26, 27, 30, 39) in symptom burden or resolution of symptoms between those 
who received care from nurses and from physicians, a multidisciplinary team or standard care.  
Seven RCTs (18, 21, 24, 32, 33, 40, 41) found no differences in terms of symptom burden 
between nurse-led and physician-led (33, 40, 41) or team-based (21) care. These trials were 
conducted in a range of patient populations including: acute disease in a primary care setting 
such as burns, diarrhoea, back pain, upper respiratory symptoms, urinary discomfort (40); acute 
asthmatic symptoms (21); ADHD-related symptoms (41), depressive symptoms (18), post-
intensive care follow up for depressive symptoms, anxiety and post-traumatic stress (24); and 
chronic/recurrent major depression or dysthymia (32).  
 
Four trials demonstrated significant benefits or equivalent outcomes in reducing symptom 
burden using nurse-led care compared to physician-led care (23, 26, 27, 30). A RCT of 175 
patients reported a significant difference in the dyspepsia severity score, with patients in the 
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nurse-led clinic arm achieving better scores than the GP-led clinic arm (23). Another RCT of 
98 patients with end-stage renal failure investigated a nurse-led management program and 
reported significant improvements in sleep at seven weeks and 13 weeks, and kidney disease 
related symptoms at seven weeks (the week immediately after the intervention), but not at 13 
weeks (30). Two small RCTs (26, 27) of 100 and 107 patients with rheumatology-related 
conditions reported comparable levels of pain (26, 27) and morning stiffness (26) in both the 
clinical nurse specialist and physician-led arm. 
 
In addition to the 11 RCTs described in this section, one RCT (39) examined the effects of a 
nurse-led follow-up intervention compared with usual care on depressive symptoms in social-
economically disadvantaged women. This trial reported a significant reduction in depressive 
symptoms compared to the usual care arm. Control group participants were wait-listed and 
were offered a reduced form of the intervention when they completed the study (i.e. at the end 
of their nine month follow-up). The wait-list session included a one-off appointment with the 
nurse to provide single-appointment case-management services, and Medicaid training 
 
 
4.6.2 Self-management and behavioural outcomes 
Three studies (26, 31, 39) reported significant benefits of the nurse-led services in a range of 
self-management or behavioural outcomes. A RCT of 432 socio-economically disadvantaged 
women who received a public health nursing case management intervention had higher levels 
of Medicaid knowledge and skills competence (p<0.001) compared with standard care (39). A 
small RCT (n=100) that compared the care provided by clinical nurse specialist with care 
provided by junior hospital doctors for osteoarthritis were comparable in patient self-efficacy 
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(26). However, patients in the clinical nurse specialist group had better knowledge of managing 
osteoarthritis (26). Another small before and after study (n=52) demonstrated that a series of 
sessions led by a nephrology nurse practitioner (involving assessment, education, planned 
medication and life style changes) led to significant improvements in active smoking 
(p=0.003), overall self-management score (p<0.001), medication knowledge (p<0.001), 
knowledge of condition (p<0.001), healthy lifestyle (p<0.005) and medication adherence 
(p=0.044)(31).  
 
One RCT reported no significant difference in diet and fluid non-adherence between patients 
with end stage kidney disease receiving peritoneal dialysis who received the nurse-led service 
or standard care (30). One RCT measured the effects of a nurse-led intervention for patients 
with cardiovascular disease on behavioural outcomes including lifestyle behaviours of dietary 
intake and physical activity (19). However, the trial did not report on these outcomes. 
 
 
4.6.3. Condition-related clinical indicators  
In total, 10 studies evaluated the effects of nurse-led services compared to physician-led or 
standard care on a number of other clinical indicators. Five RCTs (21, 27, 29, 34, 38) found no 
differences between those receiving the nurse-led services and those receiving physician-
led/standard care. The populations and outcomes evaluated included GP practice: health status, 
and compliance of clinical practice guidelines(38); asthma monitoring: lung function test 
outcomes (FVC1 and PEF) (21); type 2 diabetes mellitus: HbA1c, blood pressure and lipid 
profile (34); chronic inflammatory arthritis: Disease Activity Score 28, the Health Assessment 
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Questionnaire (27); post-surgery for colorectal cancer: distress thermometer and supportive 
care needs (29). 
 
Three RCTs (19, 32, 36) and two before and after studies (31, 35) demonstrated significantly 
better outcomes in terms of a range of clinical quality indicators. A RCT of 238 people with 
HIV and mental illness reported that a community-based nurse-led intervention was effective 
for significantly reducing viral load at 12 months (p<0.001) (36). A RCT of 525 patients with 
documented cardiovascular disease reported an intervention delivered by a nurse 
practitioner/community health worker team using an individualised treatment regimen based 
on algorithms improved total cholesterol (p<0.001), LDL-C (p<0.001), triglycerides (p=0.013), 
systolic blood pressure (p=0.003), diastolic blood pressure (p=0.013), and HbA1c (p=0.034) 
(19). Another RCT of 558 people with chronic depression in the community setting reported 
significant improvements in functional impairment in those who received nurse-led regular 
follow up compared to GP-led care (p=0.010) (32).  
 
The remaining two before and after studies were conducted in women with gestational diabetes 
(n=261) (35) and people with chronic kidney disease (n=52) (31). Results from the diabetes 
study indicated that there was a statistically significant decrease in the number of cases with 
“neonatal congenital abnormality” (p<0.0001) and other adverse neonatal outcomes 
(p<0.0001) after the implementation of the nurse practitioner-led model of care (35). However, 
there were no significant differences in HbA1c and maternal adverse outcomes. The study of 
patients with chronic kidney disease (31) involved a series of sessions led by a nephrology 
nurse practitioner that included assessment, education, planned medication and life style 
changes). This intervention led to significant improvements in proteinuria (p=0.002), eGFR 
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(p=0.002), 5-year absolute risk reduction (p=0.002), systolic and diastolic blood pressure 
(p<0.01 and p<0.001, respectively), cholesterol (p=0.002), and HbA1c (p<0.001) (31).  
 
4.6.4 Satisfaction and perception on the quality of care 
Nine RCTs (19, 26, 27, 29, 30, 33, 34, 38, 40) measured satisfaction or perception on the quality 
of care from the patient’s perspective. One RCT (28) reported satisfaction from both the 
patient’s and spouse’s perspectives and one study (22) reported satisfaction from the residential 
aged care facilities management perspective. 
 
In five RCTs (27-29, 33, 38, 40) that compared care delivered by a nurse and a 
physician/standard care, there were no differences in patient’s satisfaction of care. These RCTs 
included patients with ADHD (33), general community common complaints (38, 40), 
rheumatoid/inflammatory arthritis (27), and patients requiring post-cancer surgery follow up 
(28, 29). The two RCTs that were conducted in a post-cancer surgery setting reported no 
difference in patient satisfaction between nurse-led follow up and standard care (28, 29); 
however, one trial reported nurse-led follow up resulted in higher spousal satisfaction (p=0.03) 
(28). 
 
Four RCTs (19, 26, 30, 34) reported patients receiving the nurse-led service were significantly 
more satisfied or reported higher perceived levels of quality care than those receiving the 
physician-led service. These RCTs evaluated nurse-led services compared to physician-led 
services in cardiovascular disease (19), diabetes (34), osteoarthritis (26) and renal care settings 
(30). The RCT (n=98) that was conducted in patients with end-stage kidney disease reported 
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nurse-led management significantly improved patient satisfaction at seven weeks (the week 
immediately after the intervention), but not at 13 weeks (30). 
 
One non-randomised controlled trial (22) reported that a nurse practitioner-led dementia 
outreach service in residential aged care facilities resulted in significantly higher level of staff 
satisfaction with regards to dementia care. 
 
4.6.5. Health service use 
Hospital admission, length of stay and emergency presentation 
Two before and after studies (17, 37) reported nurse-led interventions decreased length of stay, 
admission rates, and emergency presentations. A controlled before and after study in the UK 
(n=172,342) compared health service use outcomes of the intervention group (5 practices) with 
the control group (30 practices) and reported significantly improved rates of unplanned medical 
and geriatric admissions (p=0.018) and reduced length of stay ≥1 night (p=0.015) (37). Another 
before and after study (17) reported that a combined home and clinic-based nurse-led 
intervention for patients with chronic heart failure was effective in shifting inpatient care to 
outpatient nurse-led care (increased from 5.2±3.2 to 6.4±4.1 times/patient, p<0.001), thereby 
reducing hospital length of stay (5.3 days, a 26.2% decrement), and hospital admission (36 
times, 33% decrement) and emergency presentations (17).  
 
While the two before and after studies (17, 37) reported significant benefits in health service 
use, seven RCTs (20, 21, 25, 29, 30, 38, 40) showed no differences between nurse-led services 
and physician-led/surgeon-led/standard care on a range of health service use outcomes. These 
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trials were conducted in post-cancer surgery (29), pain management (25), asthma (20, 21), 
general practice (38, 40), and end-stage kidney disease (30) care settings. 
 
Referrals to specialist physicians or allied health services 
Three studies (34, 35, 39) reported that nurse-led care resulted in more appropriate referrals to 
specialist physicians or allied health professionals. A nurse-led care intervention for diabetes 
showed there were more referrals to an ophthalmologist (p=0.07), referrals to insulin therapy 
(p=0.015), measures to prevent diabetic foot symptoms (p=0.001), and mean number of visits 
(p<0.001) (34). Similarly, a before and after study demonstrated that, there was a statistically 
significant increase in insulin use and referrals to dietitians and diabetes educators, and a 
significant decrease in referral to physicians for diabetes care, (p<0.0001) after the 
implementation of the nurse practitioner led model of care (35). A RCT examining a public 
health nursing case management intervention indicated that women who received the 
intervention were twice as likely to receive new mental health visits compared to those in the 
control group (OR=1.92, p<0.007) (39). However, there was no difference in the number of 
preventive routine care visits (39). 
 
Medication Management 
Three RCTs (23, 32, 40) demonstrated varying consultation duration and prescribing patterns 
between nurses and physicians in their care. A large multicentre RCT of 1,461 participants 
compared nurses’ and physicians’ visits for the management of low complexity diseases in the 
community setting (40). In this trial, the mean visit duration by a general practitioner (GP) was 
3 minutes and 6 minutes by nurses (Mean Difference MD =3.195, 95% CI 1.466-4.924). Nurses 
prescribed drugs in 65.1% of cases, compared to 84.4% prescribed by GPs (Odds Ratio OR: 
0.24, 95%CI=0.16, -0.35) (40). Another RCT (n=558) examining practice nurse-led care 
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reported a higher number of nurse visits and months in which patients were on anti-depressant 
medications in the practice nurse group compared to the group receiving GP-led care (p=0.026 
and 0.047, respectively) (32). For dyspeptic patients, an RCT showed that the nurse practitioner 
group required significantly less “full dose protein pump inhibitors” use, more “no protein 
pump inhibitor treatment” compared to those who received GP-led care at 6 months (23). A 
small before and after study of patients with chronic kidney disease (n=52) demonstrated that 
a series of sessions led by a nephrology nurse practitioner led to significant improvements in 
the number of prescribed anti-hypertensives (p<0.001), cholesterol lowering medications (3-
hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) (p=0.003), and aspirin (p<0.001) 
(31).  
 
 
4.7. Economic outcomes 
Five studies included cost analyses (17, 23-25, 28) (Table 3), however, only one was a full 
cost-effectiveness analysis (24) where costs are considered in relation to health outcomes 
(Table 3). Four studies were randomised controlled trials (23-25, 28) and one was a pre-post 
design(17). In a Taiwanese study (17), the nurse-led intervention was the most intensive with 
2 weekly home visits initially, plus outpatient visits and telephone calls, but no intervention 
costs were reported. Other studies had less frequent contact with the nurse (several months 
apart) and relied on self-help approaches. Hernandez et al. (2014), a superiority trial, concluded 
the nurse-led intervention was not cost-effective, due to no patient quality of life improvements 
while costs for inpatient care were higher than the usual care group (24). Health service use 
costs were lower in the nurse-led interventions compared with usual care for several other 
studies; €4,004 vs €7,464 (25), €2,592 vs €3,789 (28), post-intervention US$362,722 vs pre-
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intervention US$624,020 (17), £36 vs £72 (23), but these differences were either not 
statistically significant or statistical approaches did not account for right-skewed cost data. 
Lower costs were driven by fewer hospital re-admissions, shorter length of stay or less 
medication use which are overarching goals of nurse-led models of care. However, quality of 
life measures failed to find significant patient health benefits in three studies (24, 25, 28). 
 
4.8. Key components and attributes of nurse-led services 
Three studies explicitly outlined the extensive clinical nursing experience of the nurses 
involved in the intervention (20, 28) and in the relevant specialty (20, 27, 28). However, none 
of the included studies specified whether the years of clinical experience or a master’s 
qualification was a requirement for the selection of nurses delivering the intervention. In a 
number of studies, the nurse delivering the intervention were provided with short, intensive 
training specific to the practice setting where the nurse-led service was delivered (18, 19, 27, 
32, 34, 37). The training was generally delivered by a specialist physician and/or a specialist 
nurse (18, 27), with varying levels of intensity from hours to weeks (30, 37). The training 
content included agreed treatment protocols (19), behavioural strategies that improved 
intervention adherence or behavioural change such as motivational interviewing (19, 32). Many 
studies did not specify the requirement of Master’s qualification except for those interventions 
that were delivered by nurse practitioners (31, 38). 
 
Over half of the included studies (n=13) specifically included self-management as a component 
of nurse-led care (17, 18, 20, 21, 23, 25, 26, 30-32, 36, 39). Of these studies, only two specified 
the inclusion of family as part of the self-management intervention (21, 30). In terms of 
resources available to the nurse delivering the intervention, a number of studies explicitly 
outlined that the nurse-led service was guided by clinical practice guidelines, protocols or 
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treatment algorithms (17, 20, 21, 24, 30, 34, 35, 40). In a number of studies, the nurse was 
provided with a clear referral pathway (40), access to a specialist physician (24, 26, 27) or other 
allied health professionals (35) as required. 
 
In eight studies (19-23, 31, 35, 38) evaluating nurse practitioner-led care, all nurse practitioners 
could prescribe or adjust the dosage of medications. In three studies (33, 34, 40), the nurse 
delivering the intervention were not nurse practitioners but were able to prescribe or adjust 
medications within an established protocol.  
 
5. Discussion 
To the best of our knowledge, this systematic review is the largest review examining the effects 
of a nurse-led model of care in the ambulatory setting, including 25 original research studies 
of 180,308 participants. While several reviews exist in the literature (11, 43, 44), this review 
specifically focussed on studies that examined models of care where registered nurses have the 
primary responsibilities of care over the patient’s condition. Of the 17 studies that reported 
HRQoL as an outcome measure (18, 20-26, 28-30, 32-34, 38, 39), 13 reported equivocal 
outcomes (20-22, 24, 25, 27-30, 32, 33, 38, 39), three (18, 23, 30) reported superior outcomes 
and one (34) reported a small reduction in a single HRQoL domain. Although many of the 
studies had methodological short-comings in terms of risk of bias, this systematic review 
affirms findings of previous reviews (43) that appropriately trained nurses can produce high-
quality care on par with physicians and achieve comparable health outcomes for patients. 
Further, no safety concerns were reported by any of the included studies. Of the three studies 
(27, 35, 40) that measured adverse events, two reported no adverse events (27, 40) and one (35) 
reported that the cohort receiving nurse-led care had significantly less adverse neonatal events. 
Therefore, we concluded that nurse-led care is a safe and feasible model of care for 
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consideration across several settings. However, it remains unclear whether nurse-led models 
are cost-saving or cost-effective compared to usual care or alternative models of care such as 
physician-led care. 
 
Due to the nature of nurse-led services, the interventions were not amenable to blinding of 
participants and personnel. All 25 studies received a high-risk assessment for this domain of 
assessment. Blinding of outcome assessment could have been achieved by using data collectors 
who are blinded to the intervention or objective outcomes such as laboratory markers. Future 
studies should ensure their study designs eliminate risks of biases in the allocation concealment 
and selecting outcome reporting domains. It is extremely important for studies to report on all 
outcomes measured, regardless of direction of results. 
 
Nurse-led services are complex interventions (5) and each component of the intervention 
requires careful consideration and planning. According to the findings from this review, we 
propose several key areas for consideration during in the design of future nurse-led models of 
care and intervention (See Supplementary Material 2). These include documenting: the years 
of experience in nursing and the specialty; formal qualification and intensive training required 
for the proposed care population; the appropriateness of clinical privileges such as prescription 
of medications; whether behavioural change is an objective of the intervention; the use of 
evidence-based clinical guidelines; the nurse’s ability to access a specialist physician and other 
allied health team members when required. 
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With regards to cost effectiveness, the five included studies that measured costs (17, 23-25, 28) 
cannot answer the question of whether nurse-led interventions had positive economic 
outcomes. Limitations in these studies included: small samples for assessing differences in 
costs (17, 23-25, 28), limited scope of cost types considered (e.g. no medication costs for 
patients with pain (25), no intervention costs considered(17, 23, 28) and incorrect statistical 
analysis of cost data (17, 23)).  One study (24) concluded the nurse-led intervention was not 
cost-effective, due to no patient quality of life improvements while costs for inpatient care were 
higher than the usual care group (24). The EQ-5D data collection in this study may not have 
been collected frequently enough or at the correct intervals or may not have been sensitive to 
this patient group (24). However, it may also mean the intervention was not of high enough 
frequency to improve patient outcomes. We recommend that all future trials should include a 
well-designed economic evaluation or cost-analysis that overcome the abovementioned flaws. 
 
Another challenge is the selection of the right outcomes for assessing the effects of nurse-led 
services. The outcomes should match the intent of the nurse-led service under testing. It is 
critical to define what an alternative model of nurse-led care attempts to achieve and to consider 
the sensitivity and appropriateness of the outcomes measures (37). Given self-management and 
behavioural change was a key component of the interventions included in 13 studies (17, 18, 
20, 21, 23, 25, 26, 30-32, 36, 39), only four studies (26, 30, 31, 39) measured and reported on 
these self-management or behavioural outcomes. From the findings of this review, we 
recommend a taxonomy of outcomes for consideration for future service evaluation and 
research (Supplementary Material 3). These include HRQoL (general and disease-specific), 
symptom burden, self-management and behavioural outcomes, health service/resources use 
and costs, satisfaction and perception of care, and other relevant clinical indicators. If there is 
a detected benefit, it is then important to consider the sustainability of such impact (30). For 
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example, patient satisfaction could be transient (30), while patients might be more satisfied 
with a recent episode of care from the nurse-led clinic, these effects might not necessarily be 
sustainable after some time (30). Further, given the rising importance of acknowledging the 
role of family members in supporting the patient in chronic disease management (45), 
measuring behavioural outcomes and satisfaction of care from the family members’ perspective 
is critical. In this review, only one trial (28) measured satisfaction from the family’s 
perspective.  
 
In terms of educational preparation, this review revealed that the nurses delivering the 
interventions had extensive clinical experience. Although the International Council of Nurses 
recommends that a master’s qualification should be required for entry-level advanced practice 
roles (8), there was a lack of (or at least a lack of description of) academic qualification 
requirements for the nurses delivering the intervention. In countries such as the United 
Kingdom and Australia, a master’s degree is mandatory educational preparation for nurse 
practitioners. Another issue is the inconsistency and variation of advanced nursing roles or 
nursing titles used across studies or countries. Although this issue is well acknowledged in the 
literature (46), this makes comparison of roles across studies difficult. It is also important to 
note that advanced nursing “roles” or “titles” should not be confused with advanced nursing 
“practice” (47). In the planning of nurse-led services whereby advanced nursing practice is 
required, it is essential to ensure the nurse can capably practise across the advanced nursing 
practice domains including direct care, support of systems, education, research and 
professional leadership (47). 
 
Nurse prescribing practices are not new, and it is well within the scope of practice of nurse 
practitioners in many countries to prescribe pharmacotherapies (48). However, there is 
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relatively less evidence suggesting the safety and effects of nurse prescribing for non-nurse 
practitioners. While acknowledging that nurse practitioners could have varying levels of 
education and preparation depending on the country or setting where they practise, nurses who 
were not nurse practitioners in three included studies (33, 34, 40) were empowered to prescribe 
and/or adjust medications. While this review cannot provide a definitive answer as to whether 
such practice should be encouraged, it is clear that such practices should be supported with 
appropriate training, the use of evidence-based clinical guidelines and algorithms, and 
professional standards and legislation.  
 
6. Conclusions 
Nurse-led care is a safe and feasible model of care for consideration across a number of settings. 
With appropriate training and support provided, nurse-led care is able to produce at least 
equivocal outcomes in terms of patient HRQoL, symptom burden, self-management and 
disease-specific clinical targets compared to physician-led care for managing chronic 
conditions. The strategic expansion of community-based nurse-led services has the potential to 
transform chronic illness care, creating a more accessible, productive and safer healthcare 
system. However, the potential economic benefits of nurse-led models compared to usual care 
or alternative models of care such as physician-led care are less certain. High quality health 
economic evaluations are urgently required to guide the decision making of health policy 
makers and service planners. It is essential that health administrators and nurse leaders 
carefully design the components of nurse-led services and measure appropriate outcomes. 
Future innovations such as prescribing practices of registered nurses should be tested and 
supported by robust evidence, training, professional standards and legislation.  
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Figure 1. PRISMA Flow Chart 
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Figure 2. Number of studies by types of outcome reporting (n=25) 
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Table 1. Characteristics and key findings of the included studies (n=25) 
Author and 
Year 
Design, Sample 
Size, and 
Country 
Setting and 
patient group 
Intervention Arms Outcome measures and follow up time points Key findings (1) Key components required to 
implement effective services 
(2) Was it clear that self-management 
support was a component of the 
intervention? 
(3) Was the nurse interventionist able to 
prescribe/adjust dosage of medications? 
Martensson et 
al. 2005(19) 
 
Cluster RCT 
 
N=153 
 
Sweden 
Heart failure in 
primary care  
 
Nurse-led intervention for 
patient self-management (1 
extension education and 
counselling session lasting for 2 
hours, with a 12-month 
telephone follow up period)  
Vs.  
Standard Care (team-based care 
including care from primary care 
physicians, nurse assistant 
nurses and a physiotherapist) 
HRQoL using the SF-36 health survey and the 
Minnesota Living with Heart Failure 
questionnaire. Depression using the Zung Self-
Rated Depression Scale 
 
Time of enrolment, baseline, 3 and 12 months 
The intervention group reported 
significantly improved role function 
due to physical limitations (P= 
0.008) and moderate/severe 
depression (p=0.023) at 3-month 
follow-up.  
 
No other significant between-group 
differences were reported. 
(1) Training related to patient 
counselling that is targeted to 
specific diseases. The training was 
offered to primary care nurses and 
physicians by a heart failure nurse 
and a cardiologist. The program 
aimed at increasing the competence 
for providing heart failure care at 
the primary health care centres. 
(2) Yes 
(3) No 
Nathan et al. 
2006(21) 
 
RCT 
 
N=154 
 
United Kingdom 
 
Acute asthma 
outpatient 
discharge 
follow-up care 
 
 
Nurse-led regular follow-up 
appointments (medical review, 
patient education, and a self-
management asthma plan) 
vs.  
Doctor-led regular follow-up 
appointments 
 
Both arms received an initial 30-
min follow up clinic appointment 
within 2 weeks after discharge 
and at 6 months  
Number of exacerbations, Number of 
participants reporting exacerbations, Mean 
number of exacerbations per person, Hospital 
readmissions, Emergency nebulisation, HRQoL 
using the Asthma Questionnaire 20 and St. 
George Respiratory Questionnaire, change in 
peak flow, follow up clinics attended and 
arranged. 
 
2-weeks and 6 months’ post-discharge 
Follow up by a nurse specialist for 
patients discharged from the 
hospital following acute asthma 
can be delivered equivocally 
compared to follow up delivered by 
a doctor. 
 
No significant difference in 
reported outcomes. 
 
(1) Use of a structured intervention 
program delivered by an 
experienced specialist nurse. The 
intervention was pre-determined 
according to national and 
international guidelines. 
(2) Yes 
(3) Yes (nurse practitioner) 
 
 
Ho et al. 
2007(49) 
 
Chronic heart 
failure  
Nurse-led home and clinic based 
program incorporating 
telephone follow up (history 
taking, physical examination, 
Economic evaluation of nurse-led program 
 
Pre-intervention and 6 months’ post-
intervention 
Introduction of intervention was 
associated with an improved 
functional class (p<0.001), average 
fee for visiting emergency services 
(1) Use of American College of 
Cardiology and American Heart 
Association guidelines for health 
failure management 
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Before and 
After study  
 
N=247 
 
Taiwan 
health education re. heart 
failure) 
vs.  
Standard care (pre-introduction 
of intervention) 
(p=0.02). Frequency of visiting 
outpatient clinics increased 
(p<0.001). 
(2) Yes 
(3) No 
Huws et al. 
2008(38) 
 
Before and 
After and 
controlled 
prospective trial 
 
Time point 1: 
86,048 
Time point 2: 
86,294 
 
United Kingdom 
NHS Primary 
Care Practices 
 
Unplanned 
medical and 
geriatric hospital 
admission 
management 
 
 
Nurse-led case management  
vs  
Standard care (pre-introduction 
of intervention) 
Hospital admissions and re-admissions 
 
12 months pre- and 12 months’ post-
implementation of intervention 
In the intervention group, there 
were significantly improved rates 
of unplanned medical and geriatric 
admission lower (p=0.018), length 
of stay ≥1 night (p=0.015). There 
were no other significant 
differences reported 
(1) An intensive (8-week) training was 
provided to the advanced practice 
nurses on individual patient 
management 
(2) No 
(3) No 
Sorensen et al. 
2008(26) 
 
RCT 
 
N= 102 
 
Denmark 
Chronic pain 
outpatient care 
 
 
Nurse-led regular follow-up 
appointments (immediately after 
discharge from multidisciplinary 
pain centre, 4, 8, 12,16,20,24 
months)  
vs  
Standard care (no additional 
follow up services) 
  
HRQoL using the SF-36 health questionnaire, 
Cost intervention, Cost to healthcare services 
 
Baseline, 24 months 
No significant difference in 
reported outcomes 
(1) N/A 
(2) Yes  
(3) No 
 
Willems et al. 
2008(22) 
 
RCT 
 
N= 109 
 
The 
Netherlands 
Asthma follow-
up care 
 
 
Nurse-led tele-monitoring 
follow-up care  
vs  
Standard care 
Asthma-related HRQoL using the AQLQ in 
adults and the paediatric AQLQ in children, 
clinical asthma symptoms, medical 
consumption, lung function 
 
Self-reported outcomes: Baseline, 4, 8, 12 
months 
Lung function: baseline and 12 months 
No significant difference in 
reported outcomes 
 
The tele-monitoring programon its 
own is no guarantee of success 
(1) This followed an asthma 
management protocol based on the 
Global Initiative for Asthma 
guidelines and the Dutch College of 
General Practitioner. The nurse was 
able to decrease (after 3 months of 
stable asthma) or increase asthma 
medication by one step. 
(2) Yes  
(3) Yes 
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Chan et al. 
2009(24) 
 
RCT 
 
N=175 
 
United Kingdom 
Outpatient clinic 
for dyspepsia 
 
 
Nurse Practitioner-led 
outpatient clinic  
vs  
Usual Care (General practitioner 
care) 
Dyspepsia using the Glasgow Dyspepsia 
severity scores, Health status and HRQoL using 
the Health Status Short Form 12, weight, 
medication cost, use of ulcer healing drugs 
 
Baseline, 6 months 
Intervention group reported a 
significant improvement in 
dyspepsia score (p<0.001), health 
status (p<0.001), medication costs 
(p<0.001), and consumed less full-
dose proton pump inhibitors 
(p<0.001) 
(1) Referral pathways to nurse-led 
clinics 
(2) Yes 
(3) Yes (Nurse Practitioners) 
Dierick-van 
Daele et al. 
2009(39) 
 
RCT 
 
N= 1501 
 
The 
Netherlands 
Community 
general 
practitioners 
clinics 
 
 
Nurse Practitioner-led 
consultation for common 
complaints vs General 
practitioner-led consultation 
 
 
Patient perceptions of quality of care, 
Effectiveness of the consultation and follow-up 
consultations, Medical resource consumption, 
Compliance with practice guidelines for 
general practitioners, Duration of consultation 
 
Baseline, Directly after the consultation, two 
weeks after the consultation. 
Patients within the intervention 
group who reported at least one 
other disease were significantly 
more satisfied with their 
consultation (p value not 
reported),. Nurse practitioners 
spent an average of 12.22±5.7 in 
face-to-face contact with patients, 
compared with 9.20±4.8 minutes 
for GPs (P < 0.001). Patients within 
intervention group were most likely 
to be asked to return for additional 
consult than control (P=0.001) 
 
No significant difference in 
reported all other outcomes 
 
(1) Use of experienced nurses to aid in 
rapport building, specialised 
education to prepare nurses for 
nurse-led roles 
(2) No 
(3) Yes (Nurse Practitioners) 
Hill et al. 
2009(27) 
 
RCT 
 
N=100 
 
United Kingdom 
Consultant 
rheumatology 
clinic 
(Osteoarthritis)  
 
 
Nurse-led symptom 
management vs Junior physician 
care 
Pain using a visual analogue scale, physical 
function assessed by duration of morning 
stiffness, self-efficacy using the arthritis self–
efficacy scale, psychological health using the 
Arthritis Impact Measurement Scales, patient 
knowledge, satisfaction using the Leeds 
satisfaction Questionnaire 
 
Baseline, 16, 32, 48 weeks 
No statistical significant 
differences) in outcomes between 
clinical nurse specialists and junior 
physicians in pain, morning 
stiffness, physical function and self-
efficacy.  
 
Patients in the nurse-led group had 
significantly better knowledge and 
higher satisfaction of care (p value 
not reported). 
(1) The clinical nurse specialists had 
open access to the rheumatologist 
for conferral or referral of patients 
(2) Yes 
(3) No 
Verschuur et al. 
2009(29) 
 
Patients recently 
undergone 
intentionally 
Nurse-led follow-up care  
vs  
standard care (surgeon-led care) 
HRQoL using the EQ-5D, EQ-VAS, EORTC QLQ-
OES18, and EORTC QLQ-C30 questionnaires, 
Intervention group reported 
greater spousal satisfaction with 
care (P=0.03), Patients and spouses 
(1) Use and training of specialised 
nurses, with experience over 10 
years in cancer care 
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RCT 
 
N=109 
 
The 
Netherlands 
curative surgery 
for oesophageal 
or gastric cardia 
cancer 
 
Follow up for both groups: 6 
weeks, 3, 6, 9 and 12 months 
Patient and spouse satisfaction with care, 
medical costs 
 
HRQoL: baseline 4, 7, 13 months 
Patient satisfaction: 7 months 
Medical costs: 6 weeks, and 3, 6, 9, and 12 
months 
in control reported that the care 
received did fulfil their 
expectations and received more 
advice regarding disease 
management (P=0.04 and 0.03, 
respectively).  
Costs of intervention follow-up 
visits were significantly lower than 
those of standard follow-up visits 
(P<0.001). No significant difference 
in measures of QoL or other 
reported measures. 
(2) No 
(3) No 
Chow et al. 
2010(31) 
 
RCT 
 
N=100 
 
Hong Kong 
 
Peritoneal 
dialysis unit and 
discharge for 
end-stage renal 
failure patients 
Nurse-led discharge planning 
using motivational interviewing 
plus weekly follow-up meetings 
(6-weeks)  
vs  
Standard care (information, 
telephone hotline service, 
printed materials and a reminder 
to attend outpatient clinic) 
HRQoL using the Kidney Disease Quality of Life 
Short Form 
 
Baseline, 6 weeks, 12 weeks 
No statistically significant 
difference in QoL between groups. 
Statistically significant within-group 
effects were found for 
symptoms/problems, effects of 
kidney disease, sleep, role-physical, 
pain, emotional wellbeing and 
social function.  
Statistically significant interaction 
effects were demonstrated for staff 
encouragement, patient 
satisfaction, sleep and social 
function. 
(1) The intervention protocol was 
developed by the researchers and 
reviewed by experienced renal 
nurses and physicians. Telephone 
interviews can be used effectively to 
improve clinical outcomes.  
(2)  Yes (including patient and family 
members in the self-management 
intervention) 
(3) No 
Blank et al. 
2010(37) 
 
RCT 
 
N=238 
 
United States of 
America 
 
Community 
patients with 
HIV and serious 
mental health 
illness 
Nurse-led in-home consultations 
and coordinated medical and 
mental health services 
(minimum one visit per week 
and coordinated clients medical 
and mental health care for 12 
months)  
vs  
Standard care 
Adherence to HAART, viral load and CD4 count 
 
Baseline, 3 months, 6 months, 12 months, 24 
months 
Greater level of HAART adherence 
in the intervention group 
compared to control at 6 and 12 
months (p= 0.03 and 0.05, 
respectively). A subset and ITT 
analysis of the intervention group 
reported a significant difference in 
log10 viral load (p≤.001) at 12 
months compared to baseline. No 
significant difference in CD4 count 
and detectable viral load was 
reported. 
(1) The intervention was designed using 
a reasoned action model 
(2) Yes 
(3) No (the APN collaborated with 
prescribing providers, pharmacists 
and case managers to organise 
medication regimens) 
Wong et al. 
2010(50) 
Renal outpatient 
care 
Nurse-led follow-up care vs 
Standard care 
Adherence to diet/fluid advice using a 
modified version of the dialysis diet and fluid 
Patient satisfaction was higher in 
the intervention group at second 
(1) Utilising staff and relevant 
stakeholders that hold rapport or 
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RCT 
 
N= 98 
 
Hong Kong 
non-adherence questionnaire, HRQoL using 
the Kidney Disease Quality of Life, patient 
satisfaction using the La Monica-Oberst Patient 
Satisfaction Scale, symptom and complication 
control, health service utilization 
 
Baseline, 7 weeks, 13 weeks 
time point (p = 0.01). Significant 
differences for HRQoL measures 
relating to sleep and symptom 
(p<0.001). No other significant 
between-group differences 
reported. 
skill-set relevant to the target 
population 
(2) Yes 
(3) No 
Allen et al. 
2011(20) 
 
RCT 
 
N=525 
 
United States of 
America 
 
Community 
health centres 
Nurse practitioner-led intensive 
management program for 
patients with CVD risk factors 
(patients were followed for 12 
year) 
vs  
Usual care combined with 
feedback on CVD risk factors 
 
 
Lipids (TC, LDL-C, triglycerides), BP, HBA1C, 
patients’ perceptions of the quality of their 
chronic illness care using the Patient 
Assessment of Chronic Illness Care Survey, 
lifestyle behaviours of dietary intake measured 
by the Habits and History Food Frequency 
Questionnaire, physical activity using the 
Stanford 7-day physical activity recall, HRQoL 
using the EQ5D 
 
Baseline, One year 
Compared with control patients in 
the intervention group had 
significantly greater improvement 
in total cholesterol (p<0.001), LDL-
C (p<0.001), triglycerides (p=0.013), 
systolic blood pressure (p=0.003), 
diastolic blood pressure (p=0.013), 
HbA1c (p=0.034), and perceptions 
of the quality of their chronic 
illness care (p=0.034) 
(1) Strong collaboration between the 
NP and community health workers 
with an expertise of working with 
underserved minority populations is 
required. The NP and the 
Community Health Worker were 
trained in motivational interviewing 
behaviour change techniques. 
Treatment algorithms were pre-
developed. 
(2) Yes 
(3) Yes (Provided by Nurse Practitioner) 
Borbasi et al. 
2011(23) 
 
Before and 
after, non-
randomised, 
controlled, 
study 
 
N=320 
 
Australia 
Aged care 
facilities 
Nurse Practitioner-led Dementia 
Outreach Service vs Standard 
care (without the Nurse 
Practitioner service) 
 
 
HRQoL of patients as determined by staff using 
an amended version of the Dementia Quality 
of Life tool 
 
Authors self-designed questionnaires for 
assessing stress, knowledge, self-confidence of 
staff (no details on the validity of these 
questionnaires available) 
 
Baseline (pre-intervention), immediately after 
implementation of intervention, and 3-6 
months’ post-baseline 
No significant differences were 
reported for all outcomes assessed, 
except for the increased level of 
staff self-confidence on the 
intervention group in comparison 
with the control group.  
(1) The service was led by a NP, 
supported by a team including 
clinical nurse, endorsed enrolled 
nurse, assistant in nursing, clinical 
facilitator, social worker and 
administrative assistant.  
(2) No 
(3) Yes (provided by Nurse Practitioner) 
Foreman et al. 
2011(34) 
 
Non-
Randomised, 
controlled 
intervention 
trial  
ADHD clinic Specialist Nurse-led follow-up 
consultation vs Physician-led 
consultation 
Clinical symptoms using the Strengths and 
Difficulties Questionnaire, side-effects using a 
clinic-developed side-effect questionnaire, 
patient satisfaction using the Commission for 
Health Improvement patient satisfaction 
questionnaire 
 
Follow up time points not available 
No significant differences reported (1) The service needs to be provided by 
a Specialist Nurse with prescribing 
right – non-medical prescribing 
qualification) 
(2) No 
(3) Yes (as above)  
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N= 70 
 
United Kingdom 
Houweling et al. 
2011(35) 
 
RCT 
 
N=230 
 
The 
Netherlands 
Diabetes 
management 
Nurse-led diabetes management 
vs Standard care (GP Care) 
HbA1c, Blood pressure, cholesterol measures, 
glycaemic control, changes in treatment 
(referrals, drug intensification), HRQOL using 
the SF-36, patient satisfaction, healthcare 
consumption 
 
Baseline, 14 months 
In the intervention group, there 
was a greater level of referrals to 
an ophthalmologist (p=0.07), 
referrals to insulin therapy 
(p=0.015), measures to prevent 
diabetic foot symptoms (p=0.001), 
and mean number of visits 
(p<0.001). There were no other 
significant differences reported. 
(1) The two Practice Nurses received 
one week training on a detailed 
treatment and management 
protocol. These nurses were also 
empowered to prescribe/adjust 
medications and order laboratory 
tests. 
(2) No 
(3) Yes (the PNs were non nurse 
practitioners who were allowed to 
prescribe 14 different medications 
and to adjust dosages for a further 
30) 
Kneipp et al. 
2011(40) 
 
RCT 
 
N=432 
 
United States of 
America 
 
 
Community 
chronic disease 
management 
Nurse-led 9-month intervention 
vs waitlist group 
 
Depression using the BDI-II tool, General 
health and HRQoL using the SF-12v2 
questionnaire, functional status using items 
from the SF-12v2, Health care knowledge and 
use 
 
Baseline, 3 months, 6 months, and 9 months 
Intervention group reported 
statistically significant 
improvement in depression and 
functional status scores (p=0.016 
for each), healthcare use (p=0.007) 
and Medicaid knowledge (p<0.001) 
(1) The skill building in women was 
grounded within the Transactional 
Model of Stress and Coping, and 
employed cognitive behavioural 
stress management therapy 
techniques.  The intervention was 
specifically helping participants to 
be gain a range of relevant self-
management and coping skills. 
(2) Yes 
(3) No  
 
Iglesias et al. 
2013(41) 
 
RCT 
 
N= 1461 
 
Spain 
 
Community 
management of 
low complexity 
diseases 
Nurse-led consultation vs 
Consultation with General 
Practitioner 
Patient satisfaction; resolution of symptoms; 
rates of revisit for same symptoms, hospital 
admissions, duration of the visit, patient 
perceived quality of care, use of resources on 
drug prescriptions and sick leave, the patient’s 
preference of care 
 
Two weeks’ post-consultation 
No significant difference between 
intervention and control group 
reported 
(1) Nurses were trained in relation to 
treatment guidelines for common 
diseases; and was provided with  
referral pathways for more complex 
cases. Nurses could also access to 
an electronic application which 
included the guideline, designed as 
a decision-making support tool. 
(2) No 
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(3) Yes (Nurses were not nurse 
practitioners, but were empowered 
to prescribe) 
Larsson et al. 
2014(28) 
 
RCT 
 
N= 107 
 
Sweden 
Rheumatology 
clinic 
Nurse-led 6-month consultation 
vs Rheumatologist-led 
consultation 
Disease severity using the DAS28 and DAS-CRP, 
patient satisfaction with care, CRP, HRQoL 
using the HAQ, pain using VAS 
 
Baseline, 6 months, 12 months 
Statistically significant (but non-
clinically) difference in CRP 
(p=0.03) between intervention and 
control at 12 months. There was no 
other significant difference in 
outcomes. 
(1) Nurses had extensive experience 
(with 22-39 years of experience and 
9-20 years of experience of 
managing rheumatic diseases). 
Nurses had access to 
rheumatologists as required. They 
received special training from a 
rheumatologist and RA instructor 
(2) Yes 
(3) No 
Murfet et al. 
2013(36) 
 
Uncontrolled 
pre-post 
intervention 
audit 
 
N=261 
 
Australia 
Gestational 
diabetes care 
Nurse Practitioner-led diabetes 
management program vs 
Standard care 
HBA1C, Healthcare referrals and use, adverse 
maternal and neonatal events 
 
Pre-intervention: July 2003–June 2006, Post-
intervention:  January 2010–December 2011 
During the post-intervention 
period, there was a statistically 
significant increase in referrals to 
dietitians and diabetes educators 
and insulin use, a significant 
decrease in referral to physicians 
for diabetes care and adverse 
neonatal outcomes (p<0.0001 for 
all measures).No significant 
difference in HbA1c and maternal 
adverse outcomes. 
(1) The nurse-led model is supported by 
dietitians and diabetes educator at 
the same location of the nurse-led 
clinic. Nurse-led care is guided by an 
evidence-based screening and 
management protocol 
(2) No 
(3) Yes (Delivered by Nurse 
Practitioner)  
Young et al. 
2013(30) 
 
RCT 
 
N=755 
 
Australia 
 
Post-surgery for 
colorectal 
cancer 
Nurse-led telephone follow-up 
care at 3, 10 days, 1,3,6 months  
vs Standard care 
HRQoL using FACT-C, Distress Thermometer 
tool, Supportive Care Needs Survey Short Form 
(SCNS-SF 34), Postoperative health services 
utilization (unplanned readmissions; 
emergency room presentations), patient 
experience of cancer-care coordination 
 
Baseline, 1, 3, and 6 months after discharge 
No significant difference in 
reported outcomes 
(1) A tailored approach might be 
required, as this intervention did 
not have any benefits according to 
the results. 
(2) No  
(3) No 
Walker et al. 
2014(32) 
 
Before and 
After Study 
 
Community 
renal patients 
Nurse Practitioner-led education 
and individualised care 
Change in proteinuria, eGFR, 5-year absolute 
CVD risk, blood pressure, serum total 
cholesterol, HbA1c, BMI, overall self-
management, overall medical knowledge 
adherence to medication and adoption of a 
healthy lifestyle 
Significant improvements in 
proteinuria (p=0.002), eGFR 
(p=0.002), 5-year absolute risk 
reduction (p=0.002), systolic and 
diastolic blood pressure (p<0.01 
and p<0.001, respectively), 
(1) Use of a nephrology nurse 
(Additional qualifications, able to 
work autonomously, and assess, 
diagnose and prescribe within their 
scope of practice) 
(2) Yes 
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N=52 
 
Australia 
 
 
Baseline, 3, 6, 9 and 12 months 
cholesterol (p=0.002), HbA1c 
(p<0.001), active smoking 
(p=0.003), overall self-management 
score (p<0.001), medication 
knowledge (p<0.001), knowledge 
of condition (p<0.001), healthy 
lifestyle (p<0.001), number of 
prescribed hypertensives 
(p<0.001), HMG-COA reductase 
inhibitors (p=0.003), and aspirin 
(p<0.001) 
(3) Yes 
Hernandez et al. 
2014(25) 
 
RCT 
 
N=286 
 
United Kingdom 
Post-Intensive 
care 
Nurse-led intensive care follow-
up clinics 
vs  
Standard care (no intensive care 
follow up after hospital 
discharge, follow up by their GP 
as required) 
HRQoL using the SF36, EQ-5D, depressive 
symptoms, anxiety (Hospital Anxiety and 
Depression Score) and post-traumatic stress 
(David trauma score), use of other primary and 
secondary care resource use, Resource use and 
cost of the nurse-led clinics, Use and cost of 
medications 
 
Baseline, 6 months, 12 months 
There was no difference in EQ5D, 
SF36, depressive symptoms, 
anxiety and post-traumatic stress 
at 6 months or 12 months.  
 
Nurse-led intervention was more 
expensive than standard care 
(£5,789 for standard care and 
£7,577 for intervention). No 
significant difference in any other 
reported outcome. 
(1) The format and content of the 
intervention was guided by national 
guidelines, national survey of 
practices, and the extensive 
experience of the clinicians. A 
Consultant Intensivist was available 
as required. 
(2) No 
(3) No 
 
Buszewicz. 
2016(33) 
 
RCT 
 
N=558 
 
United Kingdom 
 
Community 
mental health 
(chronic 
depression) 
Nurse-led regular follow-up 
appointments 
Vs 
Standard care (GP-led care) 
Depression severity using the BDI-II, HRQoL 
using the EQ-5D, DSM-IV diagnosis and 
frequency of depressive episodes assessed 
using the CIDI questionnaire, functional 
impairment using the Work and Social Activity 
Scale; Practice Service Data on GP visits, 
practice nurse contacts, referrals for 
psychological therapy and prescription for 
psychotropic medication 
 
Baseline, and 24 months. Depression: baseline, 
3, 6, 12, 18, and 24 months 
No significant difference in 
depression scores between groups. 
Functional impairment significantly 
improved in the intervention group 
compared to the control group 
(P=0.010). Intervention group had a 
higher number of nurse visits and 
months on anti-depressant 
medications compared to control 
(P=0.026 and 0.047, respectively). 
No statistically significant 
difference in diagnostic category 
reported (P=0.368). 
Contamination-adjusted ITT 
analysis found significant 
improvement in depression 
(1) Adequate training specific to the 
disease population concerning 
mental illness, use of motivational 
interviewing to improve 
intervention adherence 
(2) Yes 
(3) No (number of prescription of 
psychotropic medication was 
assessed between the two groups. 
However, it was not explicit 
whether the nurse was able to 
prescribe). 
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(P=0.004) and QoL (P=0.004) scores 
per nurse treatment-session 
Note.  
AQLQ, Asthma Quality of Life Questionnaire; BDI-II, Beck Depression Inventory-II; BMI, Body Mass Index; CRP, C-reactive protein; CVD, cardiovascular disease; DAS28, Disease Activity Score; 
DSM, Diagnostic and Statistical Manual of Mental Disorders; eGFR, Estimated Glomerular Filtration Rate; EQ5D, EuroQol 5 Dimension; EQ-VAS, EuroQol Visual Analogue Scale; EORTC QLQ 
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire; FACT-C, Functional Assessment of Cancer Therapy-Colorectal; HAART, Highly active antiretroviral 
therapy; HAQ, Health Assessment Questionnaire; HMG-COA, Hydroxymethylglutaryl-CoA; ITT, Intention To Treat; HRQoL, Health Related Quality of Life; NHS, National Health Service; SF-36, 
Short Form Health Survey-36 
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Table 2. Risk of Bias Assessment of the included studies (n=25) 
Study ID Random 
sequence 
generation 
Allocation 
Concealment 
Blinding of 
participants 
Blinding of 
outcome 
Incomplete 
data 
Selective 
Outcome 
Reporting 
Other 
sources 
of bias 
Martensson et al. 
2005 
L H H H L U L 
Nathan et al. 2006 L U H L L H L 
Ho et al. 2007 N/A N/A H H U U H 
Huws et al. 2008 N/A N/A H H U L H 
Sorensen et al. 
2008 
L L H H H H L 
Willems et al. 
2008 
L H H H H L H 
Chan et al. 2009 L L H L L H L 
Dierick-van Daele 
et al. 2009 
L L H H L L L 
Hill et al. 2009 L L H L L U L 
Verschuur et al. 
2009 
L L H H L U L 
Chow et al. 2010 L U H U L L L 
Blank et al. 2010 L L H L L L L 
Wong et al. 2010 L L H L H U L 
Allen et al. 2011 L U H H L H L 
Borbasi et al. 2011 N/A N/A H H H U H 
Foreman et al. 
2011 
H H H H H U H 
Houweling et al. 
2011 
L U H U L L U 
Kneipp et al. 2011 L L H H L U L 
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Iglesias et al. 2013 L L H L L L U 
Larsson et al. 
2013 
L L H H H U L 
Murfet et al. 2013 N/A N/A H H L U U 
Young et al.2013 L L H H L L L 
Walker et al. 2014 N/A N/A H H L L L 
Hernandez et al. 
2014/ 
Cuthbertson 2009 
L L H H L L L 
Buszewicz. 2016 L L H L L L  L 
*Other sources of bias include: recruitment (selection bias), measures of exposure, measure of outcome, confounding factors and high lost to follow up. L=Low, U=Unclear, H=High, N/A= Not 
applicable as not RCT 
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Table 3. Characteristics and results of the cost utility and consequences studies (n=5) 
 
 Hernandez 2014 Sorenson 2008 Verschuur 2009 Ho 2007 Chan 2009 
Country UK Denmark The Netherlands Taiwan UK 
Trial design Pragmatic, non-blinded, multicentre 
RCT, n=286 
Prospective, RCT, n=102 Prospective RCT, n=109 Pre- post design, 6 months ea, 
n=247 
RCT, n=175 
Patient group Critical care patient Pain Oesophageal cancer Chronic heart failure Dyspeptic patients after gastroscopy 
Economic design Cost-utility  Cost consequences Cost-utility Cost consequences Cost consequences 
Time horizon 12 months post-intervention 2 years (costs pre-post) 12 months post 6 months pre and post 6 months 
Intervention Intensive care unit follow-up, base, 3, 
9 months, self-directed 
Home visits every 4 months 
(7x) 
Home visits + In-hospital 
visits,6 weeks, 3,6,9,12 months 
Home visits every 2 weeks 
initially, then OPD 2-3 mthly, & 
telephone 3-4 weekly 
Nurse outpatient 
Comparison Standard care (GP & specialist) Standard care (GP allowed) Standard care (In- hospital 
visits,6 weeks, 3,6,9,12 
months) 
intervention group are their 
own comparisons - pre 
intervention. 
Usual care - GP follow-up 
Perspective UK NHS perspective Health service Not stated Not stated Pharmacy costs only 
Main outcomes Costs, QALYs using EQ5D at baseline, 
6, 12 months 
Costs (GPs, hospital, 
intervention), SF-36 at 4 times,  
Costs (hospital, dx, 
treatments), EQ5D 
Costs (outpatient, emergency 
dept, ward) 
Drug costs, SF12, QoL, satisfaction 
Main results intervention £7,577, 0.60 QALYs  
SC £5,789, 0.58 QALYs 
No diff in SF36 at all, right 
direction though, 
intervention incr GPs and 
lowered hospitals, €4004 
intervention group, €7464 in 
control group (ns) 
EQ5D improved in both groups 
(ns), €2592 vs €3789 in 
intervention favour (ns). Less 
inpatient admissions. 
Pre US$624,020, post 
US$362,722 (42% less) 
Readmissions – same ALOS – 
lower 20 vs 14 days, ED lower 
37%. Improved compliance 
and knowledge of meds 
Qol stat sign better in intervention 
Lower ulcer healing drug use in 
intervention and cost savings £39.6 over 
6 months 
Conclusion by authors Not cost effective with SC =93% 
probability at <£20,000 per QALY 
No patient effects, big cost 
savings in intervention group 
(ns) 
Cost saving 91% prob, WTP €0, 
ignoring QoL effects 
Decreased hospital and LOS 
and cost-savings 
Good all round. Full CEA needs to be 
done. 
 
 
 
 
AC
CE
PT
ED
 M
AN
US
CR
IPT
